Ozempic’s maker is in trouble. Tablets may be the answer
Just a few years ago, Novo Nordisk was the darling of the healthcare industry. Now it is teetering.
See all — SMH.com.au →Aggregated from the leading newsrooms of the country. Every story links to its original source.







